Achiko Strengthens Leadership Team with New President and New SVP Commercialization - Seite 2

“I am delighted and excited to be joining Achiko at this pivotal moment,” said Dr. Morris S. Berrie. “The opportunity to harness the talented team and drive forward the commercialization of an exceptional and unique diagnostic product is inspiring. To do so with a product that can both do good and affect rapid change in the control and management of pathogenic disease, not least Covid-19, is truly a worthy endeavour.”

Mr. Lingard is an accomplished business leader with over 25 years’ experience in the life science industry.  He has a chemistry background and has worked with a range of multinational corporations, contract research organisations (CROs) and start-up companies.

Previously, he was CEO of Adroit-DI, where he developed a software platform to unify research. Mr. Lingard was Head of Europe, Middle East, India and Russia for Taconic Biosciences, creating a partner ecosystem and structuring his division to assist with the sale of Taconic to H.I.G. Capital.

Mr. Lingard was SVP Global Commercial Operations for Dotmatics, a global software solution and service provider, where he doubled his international team of PhD scientists, sales, and marketing to triple the business turnover in three years. Prior to that, he led business development, sales, commercialization and partnership positions at Clarivate Analytics, Thermo Fisher, Charles River, Biovia, Exelixis and Merck & Co Inc.

He holds a Bachelor of Science in Management and Chemical Sciences from the University of Manchester Institute of Science and Technology.  

“Achiko’s team and technology are positioned to democratize rapid, accurate, non-invasive Covid-19 diagnostics.  We defeat pandemics one test at a time,” said Richard Lingard, SVP of Commercialization. “I’m thrilled to join Achiko’s senior leadership team.”

“The pandemic represents a disruption in diagnostics and telehealth, especially in moving from point of care to point of need,” said Achiko CEO Steven Goh. “The addition of new senior leadership further builds on our commitment to our transformation into a leading player in diagnostics.”

About Achiko AG
We create solutions with a great user experience, for the transforming healthcare industry.

The development of our patent pending diagnostic testing kit (Gumnuts) provides for an easy and effective way to help people get the information they need. This is complemented by our mobile check-in app (Teman Sehat), enabling users to manage their own diagnostic experiences on their own terms, safeguard their privacy, share experiences and find community.